Press Releases Year All2026202520242023202220212020201920182017201620152014 Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update May 11, 2026 Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 May 04, 2026 Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update Mar 09, 2026 Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 Mar 02, 2026 Coherus Oncology to Participate in Upcoming Investor Conferences Feb 23, 2026 Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock Feb 17, 2026 Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock Feb 12, 2026 Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock Feb 12, 2026 Coherus Oncology Announces Clinical Supply Agreement to Evaluate Tagmokitug in Combination with Pasritamig Feb 04, 2026 Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference Jan 06, 2026
Year All2026202520242023202220212020201920182017201620152014 Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update May 11, 2026 Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 May 04, 2026 Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update Mar 09, 2026 Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 Mar 02, 2026 Coherus Oncology to Participate in Upcoming Investor Conferences Feb 23, 2026 Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock Feb 17, 2026 Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock Feb 12, 2026 Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock Feb 12, 2026 Coherus Oncology Announces Clinical Supply Agreement to Evaluate Tagmokitug in Combination with Pasritamig Feb 04, 2026 Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference Jan 06, 2026
Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update May 11, 2026
Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update Mar 09, 2026
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 Mar 02, 2026
Coherus Oncology Announces Clinical Supply Agreement to Evaluate Tagmokitug in Combination with Pasritamig Feb 04, 2026
